CYP3A
Lähteet:

1 2 3 4 5 6  Lyubov S. Klyushova, Maria L. Perepechaeva, Alevtina Y. Grishanova: The Role of CYP3A in Health and Disease. Biomedicines, 2022-11, 10. vsk, nro 11, s. 2686.  PubMed:36359206  doi:10.3390/biomedicines10112686  ISSN 2227-9059  Artikkelin verkkoversio. (englanniksi)
1 2 3 4  Hannu Raunio, Jukka Hakkola, Olavi Pelkonen: Regulation of CYP3A genes in the human respiratory tract. Chemico-Biological Interactions, 15.1.2005, 151. vsk, nro 2, s. 53–62.  doi:10.1016/j.cbi.2003.12.007  ISSN 0009-2797  Artikkelin verkkoversio.
↑  Lamba Jatinder, Joan Hebert, Schuetz Erin, Altman Russ: PharmGKB summary: very important pharmacogene information for CYP3A5 22.6.2012. Pharmacogenet Genomics. Viitattu 13.12.2024.
↑  Peter Kuehl, Jiong Zhang, Yvonne Lin, Jatinder Lamba, Mahfoud Assem, John Schuetz, Paul B. Watkins, Ann Daly, Steven A. Wrighton, Stephen D. Hall, Patrick Maurel, Mary Relling, Cynthia Brimer, Kazuto Yasuda, Raman Venkataramanan, Stephen Strom, Kenneth Thummel, Mark S. Boguski, Erin Schuetz: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics, 2001-04, 27. vsk, nro 4, s. 383–391.  doi:10.1038/86882  ISSN 1546-1718  Artikkelin verkkoversio. (englanniksi)
↑  CYP3A5 cytochrome P450 family 3 subfamily A member 5 [Homo sapiens (human) - Gene - NCBI] www.ncbi.nlm.nih.gov. Viitattu 13.12.2024.
1 2  CYP3A7 cytochrome P450 family 3 subfamily A member 7 [Homo sapiens (human) - Gene - NCBI] www.ncbi.nlm.nih.gov. Viitattu 13.12.2024.
↑  Paulo Caldas, Mariana Luz, Simone Baseggio, Rita Andrade, Daniel Sobral, Ana Rita Grosso: Transcription readthrough is prevalent in healthy human tissues and associated with inherent genomic features. Communications Biology, 15.1.2024, 7. vsk, nro 1, s. 1–12.  PubMed:38225287  doi:10.1038/s42003-024-05779-5  ISSN 2399-3642  Artikkelin verkkoversio. (englanniksi)
1 2 3  Li, Haixing, Lampe, Led: Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism 30.9.2020. Arch Biochem Biophys. Viitattu 13.12.2024.
1 2  CYP3A43 cytochrome P450 family 3 subfamily A member 43 [Homo sapiens (human) - Gene - NCBI] www.ncbi.nlm.nih.gov. Viitattu 13.12.2024.
↑  Christelle Cauffiez, Jean-Marc Lo-Guidice, Dany Chevalier, Delphine Allorge, Rima Hamdan, Michel Lhermitte, Jean-Jacques Lafitte, Jean-Frédéric Colombel, Christian Libersa, Franck Broly: First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: Identification of a loss-of-function variant. Human Mutation, 2004, 23. vsk, nro 1, s. 101–101.  doi:10.1002/humu.9211  ISSN 1098-1004  Artikkelin verkkoversio. (englanniksi)
1 2  Junhui Zhou, Xuan Qin, Shenzhi Zhou, Kevin R. MacKenzie, Feng Li: CYP3A-Mediated Carbon–Carbon Bond Cleavages in Drug Metabolism. Biomolecules, 2024-09, 14. vsk, nro 9, s. 1125.  PubMed:39334891  doi:10.3390/biom14091125  ISSN 2218-273X  Artikkelin verkkoversio. (englanniksi)
1 2  CYP3A4 cytochrome P450 family 3 subfamily A member 4 [Homo sapiens (human) - Gene - NCBI] www.ncbi.nlm.nih.gov. Viitattu 13.12.2024.
↑  Johanna Sistonen, Mikko Niemi: Onko farmakogeneettisestä tiedosta apua lasten yksilöllisten lääkeannosten määritykseen kasvun ja kehityksen aikana? www.duodecimlehti.fi. 2017. Lääketieteellinen Aikakauskirja Duodecim. Viitattu 13.12.2024.